#Defibrillator Market

[kishorxox]

Defibrillator Market to be Worth $22.76 Billion by 2031

Meticulous Research®—a leading market research company, published a research report titled, 'Defibrillator Market by Product (Implantable (ICD) [Transvenous {Dual Chamber, Single-chamber, CRT-D}, Subcutaneous], External (ECD) [Manual, Automated, Wearable]), End User (Hospital, Emergency Care, Home Care), Age Group – Global Forecast to 2031.’

According to this latest publication from Meticulous Research®, the defibrillator market is projected to reach $22.76 billion by 2031, at a CAGR of 6.9% from 2024 to 2031. The growth of the defibrillator market is driven by several factors, including the increasing burden of cardiovascular diseases and the rise in obesity incidence, the adoption of a sedentary lifestyle, and excessive consumption of alcohol & caffeinated products, technological advancements in defibrillator devices and the rising geriatric population. However, the lack of skilled professionals and the increase in reported cases of defibrillator malfunctions & product recalls restrains market growth.

The high incidence of clinical adverse events attributed especially to high-risk medical devices has led to an advocated change from many stakeholders. This is especially true with respect to devices like cardiac implants, with their high-risk nature and high complication rates associated with considerable mortality due to their frequent use in older populations with frequent co-morbidities. For instance, in July 2023, Medtronic plc (Ireland) recalled their Implantable Cardioverter Defibrillators (ICDs) Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) with glassed feedthrough for risk of low or no energy output during high voltage therapy. The reason for this recall was the failure of the devices to deliver low or no energy output, which can fail to correct arrhythmias, leading to cardiac arrest, other serious injuries, or death.

Key Players

The key players profiled in the defibrillator market report are Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Biotronik Se & Co., Kg (Germany), LivaNova plc (U.K.), Stryker Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), Progetti Srl (Italy), Fukuda Denshi Co., Ltd. (Japan), Schiller AG (Switzerland), and ZOLL Medical Corporation (U.S.).

The defibrillator market is segmented by Product (Implantable Cardioverter Defibrillators [Transvenous Implantable Cardioverter Defibrillators {Cardiac Resynchronization Therapy Defibrillators (CRT-D), Dual-Chamber Implantable Cardioverter Defibrillators, Single-chamber Implantable Cardioverter Defibrillators}, Subcutaneous Implantable Cardioverter Defibrillators], External Cardiac Defibrillators [Manual ECD, Automated ECD {Semi-automated ECD, Fully-automated ECD}, Wearable ECD), Age Group (Adult, Children), End User (Hospital and Ambulatory Surgery Centers, Pre Hospital/Emergency Care, Public Access Programs, Alternative/Foster Care, and Homecare), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Among products, in 2024, the implantable cardioverter defibrillators segment is expected to account for the largest share of the market. The large share of the segment is attributed to the rising adoption of permanent implantable cardioverter defibrillators for the prevention of sudden cardiac arrest and related deaths in patients at high risk of it. Technological developments leading to the development of advanced defibrillators are supporting the largest market share. For instance, in March 2022, Rapid Response Revival Research Ltd (U.K.) launched CellAED, which is a personal defibrillator, which is a handheld device that improves the chances of surviving a sudden cardiac arrest. This device is portable and easy to use and does not require any special medical training.

Among age groups, in 2024, the adult segment is expected to account for the larger share of the market. Defibrillators are used to regulate irregular heartbeats or revive the heart in case of a sudden cardiac arrest. Increasing incidence of obesity, sedentary workstyle, and excessive consumption of alcohol and caffeinated products increases the risk of cardiac arrests, particularly in the adult population, as these risk factors are more prevalent in adults than children. For instance, as per data updated by the Sudden Cardiac Arrest Foundation (U.S.), in the U.S., the annual incidence of out-of-hospital cardiac arrests (OHCA) reported is 347,322 in adults, compared to 7,037 in children. Thus, the demand for defibrillators is higher in adults compared to children.

Among end users, in 2024, the hospitals segment is expected to account for the largest share of the market. Being one of the most conventional and highly preferred healthcare settings with wide presence, easy accessibility, and better healthcare infrastructure, most of the patients initially visit hospitals for any healthcare concerns. The large share of the market is attributed to factors such as the large pool of patients with cardiovascular diseases visiting the hospitals for diagnosis & treatment of cardiac diseases, easy accessibility, and better healthcare facilities in hospitals as compared to other healthcare institutions.

Among geographies, in 2024, North America is expected to account for the largest share of the market. The U.S. is the largest share-holding country in North America. The large share of this region is attributed to factors such as increasing incidence of cardiovascular diseases among the rising geriatric population, increasing burden of hypertension; well-established healthcare system & distribution channel; higher spending on healthcare; and presence of leading players in this region. For instance, according to the Centers for Medicare & Medicaid Services (CMS), the U.S. healthcare expenditure was $4.5 trillion in 2022 as compared to $4.3 trillion in 2021. Along with this, the increasing number of chronic diseases, the presence of large medical device manufacturers in this region, and increased accessibility & higher adoption of technically advanced medical devices are driving the growth of defibrillator devices in the country.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3596

Key questions answered in the report:

Which are the high-growth market segments in terms of defibrillators by product, age group, end user, and geography?

What was the historical market for defibrillators across the globe?

What are the market forecasts and estimates for the period 2024–2031?

What are the major drivers, restraints, opportunities, and challenges in the defibrillator market?

Who are the major players operating in the defibrillator market?

What is the competitive landscape like, and who are the leaders in the defibrillator market?

What are the recent developments in the defibrillator market?

What are the different strategies adopted by the major players in the defibrillator market?

What are the geographical trends and high-growth regions/countries?

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[healthcare-updates-with-sns]

Defibrillator Market: Industry Trends and Forecast 2024-2032

The Defibrillator Market was valued at USD 7.31 billion in 2023 and is projected to reach USD 14.85 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2032. This growth is primarily driven by the increasing prevalence of sudden cardiac arrests (SCAs), technological advancements in defibrillator devices, and heightened public awareness about cardiac health.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3654

Regional Analysis

North America: Currently dominates the market due to a high incidence of cardiovascular diseases, advanced healthcare infrastructure, and supportive regulatory policies.

Europe: Holds a significant market share with increased investments in public health initiatives and rapid adoption of new technologies.

Asia-Pacific: Expected to witness the highest growth rate, driven by improving healthcare systems, growing awareness, and government programs aimed at reducing cardiovascular disease-related mortality rates.

Market Segmentation

By Product:

Implantable Cardioverter Defibrillators (ICDs)

Transvenous ICDs

External Defibrillators

By Patient Type:

Adults

Pediatric

By End User:

Hospitals

Pre-Hospital Settings

Public Access Markets

Alternate Care Markets

Home Healthcare

Key Players

The major key players are Medtronic, Stryker, Koninklijke Philips N.V., Asahi Kasei Corporation, Boston Scientific Corporation, Abbott, MicroPort Scientific Corporation, Nihon Kohden Corporation, Shenzhen Comen Medical Instruments Ltd., BIOTRONIK SE & Co. KG, Metrax GmbH, and Others.

Key Points

Increasing cases of SCAs have heightened the demand for defibrillation devices in both clinical and public settings.

Advancements in technology, such as wearable defibrillators and automated external defibrillators (AEDs) with real-time monitoring and connectivity, are improving patient outcomes.

Expansion of public access defibrillation programs ensures AED availability in high-traffic areas such as airports, schools, and sports arenas for quick emergency response.

Future Scope

The defibrillator market is set for substantial advancements with the integration of artificial intelligence (AI) and the Internet of Things (IoT). These innovations will enhance device performance by enabling predictive analytics and real-time decision-making. Additionally, collaborations between healthcare providers and manufacturers are expected to make defibrillation solutions more accessible and cost-effective, further driving market growth.

Conclusion

With the increasing prevalence of cardiovascular diseases, continuous technological innovations, and proactive public health initiatives, the defibrillator market is on a strong growth trajectory. As awareness and adoption of defibrillation devices rise globally, the market is expected to expand, offering improved solutions for cardiac care and emergency response.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Fertility Services Market

Medical Power Supply Market

Post Traumatic Stress Disorder Treatment Market

MRI Guided Neurosurgical Ablation Market

[health-views-updates]

2024-2032 Defibrillator Market Size and Revenue Growth Analysis

The Defibrillator Market Revenue was valued at USD 7.31 billion in 2023 and is anticipated to nearly double, reaching USD 14.85 billion by 2032, growing at a steady CAGR of 8.2% over the forecast period from 2024 to 2032. Increasing prevalence of cardiovascular diseases (CVDs), technological advancements, and rising awareness of the importance of timely cardiac care are key drivers propelling market growth.

Key Growth Factors

The surging incidence of sudden cardiac arrests (SCAs) worldwide has heightened the demand for effective defibrillation devices, both in healthcare settings and public spaces. Governments and private organizations are emphasizing the importance of automated external defibrillators (AEDs) to improve survival rates in emergency situations, contributing significantly to market expansion.

Technological innovations, including wearable defibrillators and advanced AEDs equipped with real-time monitoring and connectivity features, are revolutionizing the market. These devices enhance patient outcomes by enabling early intervention and seamless integration with healthcare systems for better data management.

Moreover, the expansion of public access defibrillation (PAD) programs in developed and developing nations is playing a pivotal role in boosting market adoption. These programs aim to install AEDs in high-traffic locations such as airports, schools, and sports arenas, ensuring rapid response to cardiac emergencies.

Get Free Sample Report@ https://www.snsinsider.com/sample-request/3654

Regional Insights

North America currently dominates the defibrillator market, driven by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and supportive regulatory policies. Europe follows closely, with increased investments in public health initiatives and technological adoption. Meanwhile, the Asia-Pacific region is expected to exhibit the highest growth rate during the forecast period due to improving healthcare infrastructure, growing awareness, and supportive government programs aimed at reducing CVD-related mortality rates.

Market Outlook

The future of the defibrillator market looks promising, with continuous advancements in device technology and expanding applications in both clinical and non-clinical settings. The integration of artificial intelligence (AI) and Internet of Things (IoT) capabilities is expected to further enhance device performance, enabling predictive analytics and real-time decision-making. Additionally, collaborations between healthcare providers and manufacturers are paving the way for more accessible and cost-effective defibrillation solutions.

About Us

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us

Akash Anand – Head of Business Development & Strategy Email: info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

[comparableau]

The global defibrillators market is witnessing an uptick on account of supportive legislation policies by the government of developed countries as the government in countries such as the U. S, and U. K. has mandated the installation of defibrillators at public places such as schools, government facilities, and institutes. 

[med-tech-enthusiast]

homemade anesthesia machine pt 2 and kind of an explanation of how the bellows system works. this is also on my YouTube channel btw

[meditechinsight01]

Global Implantable Defibrillator Market expands with new launches, estimated 7% CAGR by 2030

The global implantable defibrillator market is projected to grow at a CAGR of ~7% during the forecast period. The growth is primarily driven by the rising prevalence of cardiovascular diseases, advancements in device technology, growing geriatric population, and supportive healthcare policies. Increasing investment in healthcare infrastructure and emphasis on reducing sudden cardiac death rates further fuel the market growth. However, the market faces challenges such as high costs of devices and procedures, limited awareness in emerging markets, and risks associated with implantation procedures.

The implantable defibrillator market encompasses the production, distribution, and adoption of devices designed to prevent sudden cardiac death by managing life-threatening arrhythmias. It includes different types of implantable defibrillators such as transvenous, subcutaneous, and wearable models, along with supporting technologies. The market addresses a critical need in cardiovascular care, focusing on individuals at risk of ventricular tachycardia or fibrillation. Growing awareness about heart disease management and technological advancements have made implantable defibrillators an essential component of modern healthcare.

Download a free sample report for in-depth market insight https://meditechinsights.com/implantable-defibrillator-market/request-sample/

Rising cardiovascular disease burden drives implantable defibrillator market

The increasing global prevalence of cardiovascular diseases (CVDs) is a significant driver for the implantable defibrillator market. According to the WHO, an estimated 17.9 million people die each year due to CVDs, accounting for ~32% of all global deaths, with ~85% of these deaths caused by heart attack and stroke. CVDs, including arrhythmias and heart failure, hold the largest share of global mortality, underscoring the urgent need for preventive and therapeutic solutions. Implantable defibrillators are critical in reducing mortality rates by providing real-time monitoring and immediate intervention during life-threatening arrhythmias. Aging populations and lifestyle shifts, such as unhealthy diets, smoking, and physical inactivity, have exacerbated CVD rates. Governments and health organizations are increasingly promoting screening and treatment initiatives, while technological advancements, such as remote monitoring, enhance accessibility and reliability, ensuring sustained growth for this life-saving market.

Transformative innovations elevating implantable defibrillator technology

Technological innovations significantly enhance implantable defibrillators' functionality and appeal, driving market growth. Modern ICDs are increasingly equipped with wireless connectivity and remote monitoring capabilities, enabling healthcare providers to track patient conditions and device performance in real time. Additionally, advancements in miniaturization have led to smaller, more comfortable devices with longer battery life, improving patient compliance and satisfaction.

A major breakthrough in ICD technology is the Extravascular ICD (EV-ICD), which provides a less invasive alternative to traditional transvenous ICDs (T-ICD) while offering pacing capabilities not available in subcutaneous ICDs (S-ICDs). EV-ICDs place leads outside the bloodstream but closer to the heart than S-ICDs, reducing complications associated with transvenous lead implantation while ensuring effective defibrillation. Clinical trials for EV-ICDs have shown promising safety and efficacy results, positioning them as a next-generation solution in cardiac rhythm management.

Furthermore, companies are also integrating AI-driven analytics into ICD systems to improve arrhythmia detection accuracy and personalize treatment strategies. These advancements not only improve patient outcomes but also expand the adoption of ICDs across broader patient demographics, significantly boosting market growth.

Competitive Landscape Analysis

The global implantable defibrillator market features established and emerging players, including Abbott; Medtronic; BIOTRONIK SE & Co. KG; Boston Scientific Corporation; MicroPort Scientific Corporation; and LivaNova PLC among others. Some of the key strategies adopted by market players include product innovation and development, strategic partnerships and collaborations, and geographic expansion.

Unlock key data with a sample report for competitive analysis: https://meditechinsights.com/implantable-defibrillator-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global implantable defibrillator market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product and end-user.

Market Size & Forecast (2023-2030), By Product, USD Million

ICDs

EV-ICD

S-ICD

T-ICD

Single-chamber

Dual-chamber

CRT-D

Market Size & Forecast (2023-2030), By End-user, USD Million

Hospitals

Ambulatory Surgical Centers

Others

Market Size & Forecast (2023-2030), By Region, USD Million

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific

China

India

Japan

Rest of Asia Pacific

Latin America

Middle East & Africa

About Medi-Tech Insights Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde Associate, Medi-Tech Insights  +32 498 86 80 79  info@meditechinsights.com 

[health-views-updates]

Defibrillator Market 2024 Size, Share, Global Business Outlook and Demand Forecast by 2032

The global defibrillator market is experiencing unprecedented growth, driven by rising incidences of cardiovascular diseases and advancements in emergency medical care. According to a recent report from SNS Insider, the Defibrillator Market is projected to continue its robust expansion as healthcare systems around the world embrace new defibrillator technologies that improve response times and patient outcomes. This surge in demand reflects both the essential role of defibrillators in saving lives and the growing emphasis on preventive healthcare infrastructure across developed and developing nations.

Defibrillator Market Revenue is being propelled by a combination of factors, including technological advancements in defibrillation devices, government initiatives to promote cardiac care, and increased awareness of heart health. Automated external defibrillators (AEDs) have become more accessible and user-friendly, allowing non-medical personnel to deliver timely interventions in cases of sudden cardiac arrest (SCA). Additionally, innovations in wearable defibrillators and implantable cardioverter defibrillators (ICDs) offer promising options for high-risk patients, providing continuous monitoring and protection outside of hospital settings.

One key trend highlighted in the report is the increasing integration of artificial intelligence (AI) in defibrillator technology. AI-enabled devices are enhancing accuracy in detecting cardiac rhythms and delivering defibrillation shocks with minimal error. This not only improves patient survival rates but also opens the door to future AI applications in real-time data analytics, enabling healthcare providers to respond proactively to patient needs. Furthermore, portable defibrillators are now available in public places, such as airports, schools, and sports arenas, making life-saving devices accessible to a wider population.

Get Free Sample Report

The demand for defibrillators is also supported by favorable government initiatives and policies, particularly in the United States and Europe. In the U.S., the Federal Aviation Administration (FAA) and public health organizations mandate the availability of AEDs in certain facilities, while European nations have adopted similar regulations to safeguard public health. These measures, coupled with increased investments in healthcare infrastructure in emerging economies, are creating a conducive environment for market growth. The defibrillator market is expected to see a rise in revenue as manufacturers innovate further to meet stringent regulations and quality standards.

The report also sheds light on the challenges facing the defibrillator industry, such as high device costs and regulatory complexities, which can impact the adoption of these life-saving devices. Nevertheless, major players in the market are working to address these issues by offering affordable solutions, developing devices with improved safety features, and ensuring compliance with regulatory standards across various regions.

Market Dynamics and Competitive Landscape

The competitive landscape of the defibrillator market is marked by a mix of established companies and emerging players, each vying to strengthen their foothold through technological innovations and strategic partnerships. Major market players are investing heavily in research and development (R&D) to create advanced defibrillators with longer battery lives, wireless connectivity, and enhanced shock delivery mechanisms. By offering products with unique features and greater efficiency, these companies are poised to capture a significant share of the growing market demand.

Furthermore, partnerships between defibrillator manufacturers and healthcare institutions are paving the way for innovations that are aligned with clinical requirements and patient needs. The trend of public-private partnerships, especially in regions with less-developed healthcare infrastructure, is expected to further boost market expansion by ensuring broader access to defibrillator technology.

Regional Outlook and Market Potential

The report provides a regional analysis of the defibrillator market, identifying North America as a key region due to its well-established healthcare system and high prevalence of cardiovascular diseases. Europe and Asia-Pacific are also significant markets, with Asia-Pacific expected to experience rapid growth owing to rising healthcare spending, increasing awareness about cardiac health, and improved accessibility of advanced medical technologies. Latin America, the Middle East, and Africa are also expected to contribute to the market's growth as defibrillator technology becomes more accessible and affordable in these regions.

About Us

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us: Akash Anand – Head of Business Development & Strategy info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

[reachingeec]

CPR Blog Humor

💥 “Stayin’ Alive” Isn’t Just a Song — It’s a CPR Anthem 💃🫀

Let’s be real — no one wakes up in the morning thinking, “Today’s the day I’ll become a life-saving legend.” But here you are, reading a blog about CPR training, and that’s basically the same thing. 🎯

So, let’s talk CPR — also known as “Calmly Perform Resuscitation… and totally freak out on the inside.” Don’t worry, we’ll fix that last part.

Why Take a CPR Class?

Well, unless you plan on yelling “Somebody do something!” while everyone else stares at each other, learning CPR is kind of a big deal. You could save:

A stranger at the gym 🏋️

Your Aunt Linda at Thanksgiving (after she deep-dives into that stuffing) 🍗

Or even yourself, through the power of preparation and main character energy 💪

But Isn’t CPR Complicated?

Not really. It’s 30 compressions, 2 breaths, and 1 incredibly awkward moment if you mess up the tempo.

Pro tip: If you're doing compressions to the beat of Stayin’ Alive by the Bee Gees, you're doing it right. 🎶 (Yes, it’s literally the song they teach in class. No, you don't have to wear bell bottoms.)

What You’ll Learn

At MyCPRclass, we teach you how to:

✅ Perform CPR on adults, children, and infants ✅ Use an AED without mistaking it for a defibrillator from a sci-fi movie ✅ Stay calm in high-pressure moments (or at least fake it like a pro) ✅ Look like an absolute hero while saving lives — cape not included

We’re Open 24/7 — Because Emergencies Don’t Take Naps 😴

Middle of the night? Early morning? Lunch break? We got you. Because nothing says “I’m responsible” like scheduling CPR training at 3AM after binge-watching medical dramas.

Final Thought:

CPR isn’t just for doctors and lifeguards. It’s for anyone with a heartbeat and a desire to keep other heartbeats beating. ❤️

So sign up today — because knowing what to do before 911 shows up makes you the real MVP.

Book your CPR class today with MyCPRclass — where saving lives is serious business… but we still have fun doing it. 😄

📞 561-571-2295 🌐 www.mycprclass.com 📧 reec2023@gmail.com 📍 Miramar / Pembroke Pines & Mobile 📱 IG: @ms.cprconleche | FB: CPR Class - Reachingeec

[industrynewsupdates]

Understanding Implantable Cardioverter Defibrillators Market: Trends and Growth Drivers

The global implantable cardioverter defibrillator market size is projected to reach USD 5.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 6.4% from 2024 to 2030. The growth can be attributed to various factors, including advancements in product technology, the increasing prevalence of sudden cardiac arrest, growing public awareness about cardiac health, and supportive policies by governments and healthcare organizations. These factors collectively drive the demand for cardioverter defibrillators and contribute to the overall market expansion.

The global demand for cardiac resynchronization therapy devices (CRT-Ds) and implantable cardioverter defibrillators (ICDs) is fueled by the increasing prevalence of cardiovascular diseases and other heart ailments. Sudden cardiac arrest (SCA) remains a significant cause of mortality, with a rising incidence and associated risk factors. Heart failure contributes significantly to global health challenges and drives the need for CRT-Ds and defibrillators. In addition, the prevalence of abnormal heart rhythms, especially in older adults and individuals with coronary artery disease (CAD), further boosts the demand for ICDs. These factors highlight the growing importance of CRT-Ds and ICDs in addressing cardiovascular conditions and improving patient outcomes.

The ICD market was negatively impacted by the COVID-19 pandemic. The suspension of elective surgeries and the focus on COVID-19 patients affected the market during the first quarter of 2020. However, the pandemic accelerated the adoption of telehealth, including remote monitoring for patients with arrhythmias. Guidelines released by the Heart Rhythm Society emphasized limiting in-person visits and promoting remote care. Biotronik capitalized on this trend by promoting its implantable CRM devices with home monitoring technology. Despite the growth in cardiovascular remote monitoring, limited reimbursement in specific regions including some EU countries hindered the overall market expansion. Approximately 13 surveyed countries still do not provide reimbursement for remote technologies in the context of heart failure management.

Request Free Sample PDF of Implantable Cardioverter Defibrillators Market Size, Share & Trends Analysis Report

Implantable Cardioverter Defibrillator Market Report Highlights

• Based on product type, the ICD market is classified into transvenous implantable cardioverter-defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillator segments (S-ICDs). The T-ICDs segment dominated the market in 2023 with a revenue share of 89.83%.

• Based on type, the ICD market is classified into single-chamber ICDs, dual-chamber ICDs, and biventricular devices segments. The biventricular devices segment dominated the market in 2023 with a revenue share of 44.33%.

• Based on NYHA Class, the market is classified into NYHA Class II and NYHA Class III. The NYHA Class II segment dominated the market with a 67.72% share in 2023 and is estimated to grow at the fastest CAGR of 6.6% during the forecast period.

• Based on end-use, the ICD market is classified into hospitals, ambulatory surgical centers, and others. The hospitals segment dominated the market with a share of 86.67% in 2023 and is estimated to grow at the fastest CAGR of 6.5% during the forecast period.

• In terms of region, the North America dominated the global  market and accounted for 41.4% of the total market share in 2023. North America has a well-developed, advanced healthcare infrastructure, including hospitals, clinics, and medical facilities.

Implantable Cardioverter Defibrillator Market Segmentation

Grand View Research has segmented the global implantable cardioverter defibrillator market based on product type, type, NYHA class, end-use, and region:

Implantable Cardioverter Defibrillator Product Type Outlook (Revenue, USD Million, 2018 - 2030)

• Transvenous Implantable Cardioverter-Defibrillators

• Subcutaneous Implantable Cardioverter Defibrillators

Implantable Cardioverter Defibrillator Type Outlook (Revenue, USD Million, 2018 - 2030)

• Single Chamber ICDs

• Dual Chamber ICDs

• Biventricular Devices

Implantable Cardioverter Defibrillator NYHA Class Outlook (Revenue, USD Million, 2018 - 2030)

• NYHA Class II

• NYHA Class III

Implantable Cardioverter Defibrillator End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Ambulatory Surgical Centers

• Others

Implantable Cardioverter Defibrillator Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Sweden

o Norway

o Denmark

• Asia Pacific

o China

o Japan

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa

o Saudi Arabia

o South Africa

o UAE

o Kuwait

List of Key Players of Implantable Cardioverter Defibrillator Market

• Abbott

• Medtronic

• BIOTRONIK SE & Co. KG

• Boston Scientific Corporation

• MicroPort Scientific Corporation.

• LivaNova PLC.

Order a free sample PDF of the Implantable Cardioverter Defibrillators Market Intelligence Study, published by Grand View Research.